Kingfa Science & Technology (India) Ltd

Kingfa Science & Technology (India) Ltd

₹ 5,367 -0.06%
05 Jun - close price
About

Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]

Key Points

Product Portfolio
The company manufactures reinforced polypropylene compounds, thermoplastics elastomers, fiber-reinforced composites, and personal protective equipment (PPE) like masks and gloves. [1] In FY24, the PPE division added newer safety products for the Indian market and started trading on Nitrile gloves. [2]

  • Market Cap 7,273 Cr.
  • Current Price 5,367
  • High / Low 5,699 / 3,006
  • Stock P/E 39.3
  • Book Value 1,033
  • Dividend Yield 0.00 %
  • ROCE 23.2 %
  • ROE 17.4 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 103% CAGR over last 5 years
  • Company's median sales growth is 16.9% of last 10 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last 3 years: -7.97%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
366 339 351 394 404 416 418 440 470 462 466 489 578
311 289 306 356 354 359 362 389 409 404 405 428 497
Operating Profit 55 50 45 38 51 57 56 51 60 58 61 62 81
OPM % 15% 15% 13% 10% 13% 14% 13% 12% 13% 13% 13% 13% 14%
1 2 0 1 2 2 1 5 2 4 3 7 7
Interest 2 1 1 1 2 1 1 1 2 1 1 1 1
Depreciation 4 4 4 5 5 5 5 5 6 6 7 7 8
Profit before tax 49 47 40 32 45 52 50 49 54 54 55 61 80
Tax % 26% 25% 25% 25% 26% 25% 26% 30% 23% 26% 26% 26% 26%
37 35 30 24 34 39 37 35 42 40 41 45 59
EPS in Rs 30.24 28.93 24.44 20.09 27.70 32.26 30.77 28.60 34.60 32.86 30.36 33.33 43.65
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
219 314 427 602 702 742 627 1,048 1,404 1,488 1,745 1,996
212 288 408 560 666 698 607 966 1,276 1,303 1,520 1,734
Operating Profit 6 27 19 41 35 43 20 82 128 185 225 261
OPM % 3% 8% 5% 7% 5% 6% 3% 8% 9% 12% 13% 13%
0 1 4 6 4 3 6 -22 2 3 9 21
Interest 8 7 2 2 2 4 3 5 7 6 7 4
Depreciation 3 3 3 6 8 9 11 13 14 18 22 28
Profit before tax -5 17 18 39 29 33 12 41 110 164 206 250
Tax % -35% 38% 30% 36% 35% 26% 55% 26% 26% 25% 26% 26%
-3 11 12 25 19 25 5 31 81 123 153 185
EPS in Rs -2.49 8.93 10.24 20.35 15.74 20.33 4.39 25.29 67.22 101.17 126.22 136.71
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 10% 0% 0%
Compounded Sales Growth
10 Years: 20%
5 Years: 26%
3 Years: 12%
TTM: 14%
Compounded Profit Growth
10 Years: 33%
5 Years: 103%
3 Years: 32%
TTM: 21%
Stock Price CAGR
10 Years: 22%
5 Years: 38%
3 Years: 39%
1 Year: 67%
Return on Equity
10 Years: 15%
5 Years: 19%
3 Years: 20%
Last Year: 17%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 10 10 12 12 12 12 12 12 12 12 14
Reserves 2 109 234 293 312 336 342 372 454 576 716 1,386
75 16 42 21 17 46 71 46 42 33 43 15
41 95 119 159 210 202 246 449 502 373 384 339
Total Liabilities 125 230 405 485 551 596 671 880 1,010 994 1,156 1,754
25 29 76 88 85 107 129 126 123 252 244 300
CWIP 1 41 10 2 79 115 123 127 131 2 41 61
Investments 0 0 0 0 0 0 0 0 0 0 0 0
99 160 319 395 388 375 419 627 756 740 871 1,393
Total Assets 125 230 405 485 551 596 671 880 1,010 994 1,156 1,754

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1 19 -119 -116 96 30 -2 38 27 16 60 66
-4 -47 -18 -6 -77 -63 -14 -19 -12 2 -30 -392
5 34 137 14 -7 22 17 -14 -21 -8 -7 438
Net Cash Flow 0 6 -1 -108 12 -11 1 5 -6 10 23 112
Free Cash Flow -5 -28 -138 -127 14 -35 -17 19 3 -5 30 -45
CFO/OP -13% 72% -602% -256% 300% 111% 5% 63% 35% 29% 56% 48%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 93 99 111 110 109 97 123 99 93 99 93 98
Inventory Days 64 85 69 85 63 67 100 110 94 76 82 78
Days Payable 72 127 108 108 119 115 152 181 155 110 94 75
Cash Conversion Cycle 85 57 72 86 53 49 71 28 32 66 80 100
Working Capital Days -14 66 59 96 59 55 57 39 45 78 85 113
ROCE % 4% 22% 9% 13% 9% 10% 4% 16% 25% 30% 31% 23%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Fixed Asset Turnover
times

Log in to view insights

Please log in to see hidden values.

Login
Working Capital Turnover
times
Sales Volume
MT
Total Installed Capacity
MTPA
Number of Dedicated R&D Lines
units
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 67.02% 67.02% 67.02%
6.34% 6.35% 6.36% 6.33% 6.34% 6.35% 6.35% 6.35% 6.34% 7.78% 7.74% 7.76%
0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.00% 0.17% 0.15% 8.75% 8.75% 8.85%
18.66% 18.66% 18.64% 18.67% 18.67% 18.61% 18.65% 18.47% 18.51% 16.45% 16.50% 16.36%
No. of Shareholders 8,4909,4199,2669,4529,41410,56612,20012,15812,63612,61012,30311,991

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents